High prevalence of pre-treatment HIV drug resistance in Papua New Guinea: findings from the first nationally representative pre-treatment HIV drug resistance study

BACKGROUND: Determining the prevalence of pre-treatment HIV drug resistance (PDR) is important to assess the effectiveness of first-line therapies. To determine PDR prevalence in Papua New Guinea (PNG), we conducted a nationally representative survey. METHODS: We used a two-stage cluster sampling me...

Descripción completa

Detalles Bibliográficos
Autores principales: Gare, Janet, Toto, Ben, Pokeya, Percy, Le, Linh-Vi, Dala, Nick, Lote, Namarola, John, Bangan, Yamba, Abel, Soli, Kevin, DeVos, Joshua, Paulin, Heather, Wagar, Nick, Zheng, Du-Ping, Nishijima, Takeshi, Boas, Peniel, Kelly-Hanku, Angela, Gurung, Anup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934451/
https://www.ncbi.nlm.nih.gov/pubmed/35305571
http://dx.doi.org/10.1186/s12879-022-07264-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934451/
https://www.ncbi.nlm.nih.gov/pubmed/35305571
http://dx.doi.org/10.1186/s12879-022-07264-y

Ejemplares similares